Araştırma Makalesi

Effects of Haloperidol, Olanzapine, Risperidone And Clozapine on Mice Detrusor Muscle Using Organ Bath System

Cilt: 7 Sayı: 1 1 Mart 2022
PDF İndir
EN TR

Effects of Haloperidol, Olanzapine, Risperidone And Clozapine on Mice Detrusor Muscle Using Organ Bath System

Abstract

Objective: The bladder normally shows no contractility or activity during the filling phase. In the overactive urinary bladder, spontaneous contractions and detrusor instability are seen in the filling phase and urinary incontinence occurs. This study aims to demonstrate the effects of first-generation antipsychotic haloperidol and second-generation antipsychotics olanzapine, risperidone, and clozapine on mice isolated bladder using the organ bath system.
Materials and Methods: 63 male inbred mice were divided as saline, haloperidol 0.125 mg/kg, haloperidol 0.25 mg/kg, olanzapine 1 mg/kg, olanzapine 2 mg/kg, risperidone 0.25 mg/kg, risperidone 0.5 mg/kg, clozapine 1.25 mg/kg and clozapine 2.5 mg/kg groups. Mice were treated with drugs for 21 days. Then, the effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips.
Results: We showed that carbachol-induced contractions relaxed by isoproterenol and papaverine in mice detrusor strips obtained from olanzapine, risperidone, and clozapine treated groups. There were no significant differences in KCl-induced contractile responses among the groups.
Conclusion: Olanzapine, risperidone, and clozapine increased the isoproterenol-induced relaxations of the detrusor muscle that increased the bladder capacity. These drugs might be clinically useful for the treatment of overactive urinary bladder in patients that should use antipsychotic drugs. 

Keywords

Kaynakça

  1. Truzzi JC, Gomes CM, Bezerra CA, et al. Overactive bladder – 18 years – part I. Int Braz J Urol. 2016;42(2):188-198. doi:10.1590/S1677-5538.IBJU.2015.0365
  2. Chuang YC, Liu SP, Lee KS, et al. Prevalence of overactive bladder in China, Taiwanand South Korea: results from a cross‐sectional, population-based study. Low Urin Tract Symptoms. 2019;11(1):48-55. doi:10.1111/luts.12193
  3. Xu H, Yang HJ, Rose GM. Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse. Life Sci. 2012;91(9-10):322-328. doi:10.1016/j.lfs.2012.07.025
  4. Lee PE, Gill SS, Rochon P. Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia. Neuropsychiatr Dis Treat. 2006;2(4):521-529. doi:10.2147/nedt.2006.2.4.521
  5. Kondej M, Stępnicki P, Kaczor AA. Multi-target approach for drug discovery against schizophrenia. Int J Mol Sci. 2018;19(10):3105. doi:10.3390/ijms19103105
  6. Colli E, Digesu GA, Olivieri L. Overactive bladder treatments in early phase clinical trials. Expert Opin Investig Drugs. 2007;16(7):999-1007. doi:10.1517/13543784.16.7.999
  7. Ulak G, Gumuslu E, Mutlu O, Ertan M, Komsuoglu Celikyurt I, Akar F, Erden F. Effects of olanzapine, clozapine, risperidone and sertindole on FGF2, synapsin and NGF expression in the hippocampus of naive mice. Int J Neuropsychopharmacol. 2016; 19(Suppl 1): 63–64. doi: 10.1093/ijnp/pyw041.45
  8. Tanyeri MH, Buyukokuroglu ME, Tanyeri P, Mutlu O, Ulak G, Yildiz Akar F, Erden BF. The effects of chronic treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens. Int J Neuropsychopharmacol. 2016; 19(Suppl 1): 37. doi: 10.1093/ijnp/pyw044.648

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

1 Mart 2022

Gönderilme Tarihi

8 Aralık 2021

Kabul Tarihi

25 Ocak 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 7 Sayı: 1

Kaynak Göster

AMA
1.Tanyeri MH, Büyükokuroğlu ME, Tanyeri P, vd. Effects of Haloperidol, Olanzapine, Risperidone And Clozapine on Mice Detrusor Muscle Using Organ Bath System. OTSBD. 2022;7(1):106-111. doi:10.26453/otjhs.1034188

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya lisans verenin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.